Cytomx Therapeutics
Clinical trials sponsored by Cytomx Therapeutics, explained in plain language.
-
First human trial tests promising new cancer drug combo
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called CX-801. Researchers are testing it alone and combined with an existing immunotherapy drug (pembrolizumab) in 121 adults with advanced solid tumors that have stopped responding to standard treatments. The main goa…
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New cancer drug enters first human trials for advanced solid tumors
Disease control Recruiting nowThis is the first study in humans testing a new cancer drug called CX-2051. Researchers want to find the safest dose and see if it helps control advanced solid tumors, either by itself or combined with another cancer drug (bevacizumab). The study will enroll about 160 adults whos…
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC